Opus Genetics Receives FDA Clearance to Launch Clinical Trial for Best1 Gene Therapy

https://is1-ssl.mzstatic.com/image/thumb/Podcasts115/v4/5d/2a/05/5d2a05d6-9e8f-ebde-5b02-4e7f17c31d76/mza_720905515349598464.jpg/600x600bb.jpg

Foundation Fighting Blindness

238 episodes

2 weeks ago

The Foundation funded preclinical studies for the approach and launched Opus.

All content for Foundation Fighting Blindness is the property of Foundation Fighting Blindness and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

The Foundation funded preclinical studies for the approach and launched Opus.

Science

https://i1.sndcdn.com/avatars-YaeofrSuCwcgCMse-dnoERw-original.jpg

Opus Genetics Receives FDA Clearance to Launch Clinical Trial for Best1 Gene Therapy

Foundation Fighting Blindness

2 minutes 7 seconds

3 months ago

Opus Genetics Receives FDA Clearance to Launch Clinical Trial for Best1 Gene Therapy

The Foundation funded earlier, proof-of-concept studies for the Best1 gene therapy and later launched Opus to develop several IRD gene therapies.